Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase NA 1Phase 2/3 1Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

INDUSTRY 4OTHER 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Advanced Solid Tumors 1Advanced Cancers 1

Interventions

Cyclophosphamide 416Radiotherapy 276fludarabine 238Gemcitabine 211Cisplatin 203Nivolumab 184pembrolizumab 183Paclitaxel 176Carboplatin 168Magnetic Resonance Spectroscopy 166fludarabine phosphate 156Irinotecan 135Bevacizumab 133Cytarabine 128Specimen Handling 124Capecitabine 124Temozolomide 123Radiosurgery 118Docetaxel 116Biopsy 116Ipilimumab 113Dexamethasone 113Radiation 111Oxaliplatin 110Fluorouracil 110Rituximab 108Etoposide 108Filgrastim 99Lenalidomide 98Everolimus 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × OTHER × satraplatin × Clear all
NCT00473720 2013-01-23

Phase I Study of the Combination of Satraplatin and Abraxane in Advanced Cancers

Yale University

Phase 1 Completed
15 enrolled

Advanced Cancers

NCT01220284 2010-10-13

Satraplatin and Vinorelbine in Advanced Solid Tumors

Southern Europe New Drug Organization

Phase 1 Unknown
27 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡